癌症早筛公司Grail(GRAL)更新2025年现金消耗指引至3.1亿美元主要由于其Galleri检测产品采用率提升及合

智通财经
Yesterday
癌症早筛公司Grail(GRAL)更新2025年现金消耗指引至3.1亿美元主要由于其Galleri检测产品采用率提升及合作伙伴关系扩展。得益于检测订单增长该公司报告净亏损同比改善93%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10